Bleomycin induces E-selectin expression in cultured umbilical vein endothelial cells by increasing its mRNA levels through activation of NF-κB/Rel

Toxicology and Applied Pharmacology

Volumn 184, Issue 2, 2002, Pages 88-97

  Ishii, Hidemi ^a   Takada, Kimihiko ^a  

^a SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Bleomycin; E selectin; Endothelial cells; Pulmonary injury

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BLEOMYCIN; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; OLIGONUCLEOTIDE; PROTEIN P50; PROTEIN SUBUNIT; SYNAPTOTAGMIN;

ARTICLE; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN MOTIF; PROTEIN TRANSPORT; TOXICOKINETICS; UMBILICAL VEIN;

EID: 0036428279     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(02)99499-8     Document Type: Article

References (32)

1. Azuma, A., Takahashi, S., Nose, M., Araki K, Araki, M., Takahashi, T., Hirose, M., Kawashima, H., Miyasaka, M., and Kudoh, S. (2000). Role of E-selectin in bleomycin induced lung fibrosis in mice. Thorax 55, 147-152.
2. Binns, R. M., Licence, S. T., Harrison, A. A., Keelan, E. T., Robinson, M. K., and Haskard, D. O. (1996). In vivo E-selectin upregulation correlates early with infiltration of PMN, later with PBL entry: MAbs block both. Am. J. Physiol. 270, H183-193.
3. Blum, R. H., Carter, S. K., and Agre, K. (1973). A clinical review of bleomycin: A new antineoplastic agent. Cancer 31, 903-914.
4. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
6. Crystal, R. G., Bitterman, P. B., Rennard, S. I., Hance, A. J., and Keogh, B. A. (1984). Interstitial lung diseases of unknown cause: Disorders characterized by chronic inflammation of the lower respiratory tract. N. Engl. J. Med. 310, 154-166.
7. Ishii, H., Takada, K., Higuchi, T., and Sugiyama, J. (2000). Verotoxin-1 induces tissue factor expression in human umbilical vein endothelial cells through activation of NF-κB/Rel and AP-1. Thromb. Haemostasis 84, 712-721.
8. Iyer, S. N., Hyde, D. M., and Giri, S. N. (2000). Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation. Inflammation 24, 477-491.
9. Jaffe, E. A., Nachman, R. L., Becker, C. G., and Minick, C. R. (1973). Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745-2756.
10. Karin, M. (1995). The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16483-16486.
11. Khan, B. V., Parthasarathy, S. S., Alexander, R. W., and Medford, R. M. (1995). Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest. 95, 1262-1270.
12. Kuramochi, H., Takahashi, K., Takita, T., and Umezawa, H. (1981). An active intermediate formed in the reaction of bleomycin-Fe(II) complex with oxygen. J. Antibiot. 34, 576-582.
13. Matsuse, T., Teramoto, S., Katayama, H., Sudo, E., Ekimoto, H., Mitsuhashi, H., Uejima, Y., Fukuchi, Y., and Ouchi, Y. (1999). ICAM-1 mediates lung leukocyte recruitment but not pulmonary fibrosis in a murine model of bleomycin-induced lung injury. Eur. Respir. J. 13, 71-77.
14. Mitsuhashi, H., Asano, S., Nonaka, T., Hamamura, J., Masuda, K., and Kiyoki, M. (1996). Administration of truncated secretory leukoprotease inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am. J. Respir. Crit. Care Med. 153, 369-374.
15. Montgomery, K. F., Osborn, L., Hession, C., Tizard, R., Goff, D., Vassallo, C., Tarr, P. I., Bomsztyk, K., Lobb, R., Harlan, J. M., and Pohlman, T. H. (1991). Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl. Acad. Sci. USA 88, 6523-6527.
16. Nagai, A., Aoshiba, K., Ishihara, Y., Inano, H., Sakamoto, K., Yamaguchi, E., Kagawa, J., and Takizawa, T. (1992). Administration of α1-proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am. Rev. Respir. Dis. 145, 651-656.
17. Oeth, P., Parry, G. C., and Mackman, N. (1997). Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-κB/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler. Thromb. Vasc. Biol. 17, 365-374.
18. Ollivier, V., Parry, G. C., Cobb, R. R., de Prost D., and Mackman, N. (1996). Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J. Biol. Chem. 271, 20828-20835.
19. Orthner, C. L., Rodgers, G. M., and Fitzgerald, L. A. (1995). Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: Evidence implicating nuclear factor-κB in TF induction by diverse agonists. Blood 86, 436-443.
20. Piguet, P. F., Kaufman, S., Barazzone, C., Muller, M., Ryffel, B., and Eugster, H. P. (1997). Resistance of TNF/LTα double deficient mice to bleomycin-induced fibrosis. Int. J. Exp. Pathol. 78, 43-48.
21. Rahman, A., Kefer, J., Bando, M., Niles, W. D., and Malik, A. B. (1998). E-selectin expression in human endothelial cells by TNF-α-induced oxidant generation and NF-κB activation. Am. J. Physiol. 275, L533-L544.
22. Read, M. A., Whitley, M. Z., Gupta, S., Pierce, J. W., Best, J., Davis, R. J., and Collins, T. (1997). Tumor necrosis factor α-induced E-selectin expression is activated by the nuclear factor-κB and c-JUN N-terminal kinase/p38 mito-gen-activated protein kinase pathways. J. Biol. Chem. 272, 2753-2761.
23. Scheule, R. K., Perkins, R. C., Hamilton, R., and Holian, A. (1992). Bleomycin stimulation of cytokine secretion by the human alveolar macrophage. Am. J. Physiol. 262, L386-L391.
24. Schindler, U., and Baichwal, V. R. (1994). Three NF-κB binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol. Cell. Biol. 14, 5820-5831.
25. Schoonbroodt, S., and Piette, J. (2000). Oxidative stress interference with the nuclear factor-κB activation pathways. Biochem. Pharmacol. 60, 1075-1083.
26. Schreiber, E., Matthias, P., Muller, M. M., and Schaffner, W. (1989). Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17, 6419.
27. Sharar, S. R., Winn, R. K., and Harlan, J. M. (1995). The adhesion cascade and anti-adhesion therapy: An overview. Springer Semin. Immunopathol. 16, 359-378.
28. Shen, A. S., Haslett, C., Feldsien, D. C., Henson, P. M., and Cherniack, R. M. (1988). The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to severity of acute injury. Am. Rev. Respir. Dis. 137, 564-571.
29. Smith, R.E., Strieter, R. M., Phan, S. H., Lukacs, N., and Kunkel, S. L. (1998). TNF and IL-6 mediate MIP-1α expression in bleomycin-induced lung injury. J. Leukocyte Biol. 64, 528-536.
30. Snider, G. L., Hayes, J. A., and Korthy, A. L. (1978). Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin: Pathology and stereology. Am. Rev. Respir. Dis. 117, 1099-1108.
31. Taooka, Y., Maeda, A., Hiyama, K., Ishioka, S., and Yamakido, M. (1997). Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Crit. Care Med. 156, 260-265.
32. Ueta, E., Osaki, T., Yoneda, K., and Yamamoto, T. (1995). Upregulation of respiratory burst of polymorphonuclear leukocytes by a bleomycin derivative, peplomycin. Free Radical Res. 22, 533-544.